nodes	percent_of_prediction	percent_of_DWPC	metapath
Mepivacaine—Cranial nerve paralysis—Vincristine—sarcoma	0.0751	0.118	CcSEcCtD
Mepivacaine—Meningism—Thiotepa—sarcoma	0.0563	0.0886	CcSEcCtD
Mepivacaine—Respiratory arrest—Thiotepa—sarcoma	0.0222	0.0349	CcSEcCtD
Mepivacaine—Paralysis—Vincristine—sarcoma	0.0125	0.0196	CcSEcCtD
Mepivacaine—Lidocaine—EGFR—sarcoma	0.0105	1	CrCbGaD
Mepivacaine—SCN10A—L1CAM interactions—EZR—sarcoma	0.0084	0.0237	CbGpPWpGaD
Mepivacaine—Apnoea—Etoposide—sarcoma	0.00828	0.013	CcSEcCtD
Mepivacaine—Swelling—Mitoxantrone—sarcoma	0.00694	0.0109	CcSEcCtD
Mepivacaine—Cardiac arrest—Thiotepa—sarcoma	0.00674	0.0106	CcSEcCtD
Mepivacaine—Urinary retention—Thiotepa—sarcoma	0.00674	0.0106	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Mitoxantrone—sarcoma	0.00633	0.00995	CcSEcCtD
Mepivacaine—Urinary retention—Vincristine—sarcoma	0.00598	0.0094	CcSEcCtD
Mepivacaine—Cardiac arrest—Vincristine—sarcoma	0.00598	0.0094	CcSEcCtD
Mepivacaine—SCN5A—L1CAM interactions—EZR—sarcoma	0.0059	0.0167	CbGpPWpGaD
Mepivacaine—Swelling—Etoposide—sarcoma	0.00577	0.00908	CcSEcCtD
Mepivacaine—Paralysis—Epirubicin—sarcoma	0.00566	0.0089	CcSEcCtD
Mepivacaine—Ventricular arrhythmia—Epirubicin—sarcoma	0.00531	0.00836	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Etoposide—sarcoma	0.00526	0.00827	CcSEcCtD
Mepivacaine—SCN5A—Cardiac Progenitor Differentiation—CXCR4—sarcoma	0.00526	0.0149	CbGpPWpGaD
Mepivacaine—Paralysis—Doxorubicin—sarcoma	0.00524	0.00824	CcSEcCtD
Mepivacaine—Sweating increased—Mitoxantrone—sarcoma	0.00515	0.00811	CcSEcCtD
Mepivacaine—Ventricular arrhythmia—Doxorubicin—sarcoma	0.00492	0.00773	CcSEcCtD
Mepivacaine—Cardiac arrest—Etoposide—sarcoma	0.00484	0.00762	CcSEcCtD
Mepivacaine—Drowsiness—Mitoxantrone—sarcoma	0.00472	0.00742	CcSEcCtD
Mepivacaine—Sweating—Vincristine—sarcoma	0.00464	0.0073	CcSEcCtD
Mepivacaine—Tinnitus—Thiotepa—sarcoma	0.00457	0.00719	CcSEcCtD
Mepivacaine—Sweating—Mitoxantrone—sarcoma	0.00452	0.00711	CcSEcCtD
Mepivacaine—SCN8A—Axon guidance—EZR—sarcoma	0.00443	0.0125	CbGpPWpGaD
Mepivacaine—Chills—Thiotepa—sarcoma	0.0044	0.00692	CcSEcCtD
Mepivacaine—Chills—Dactinomycin—sarcoma	0.00437	0.00687	CcSEcCtD
Mepivacaine—Bradycardia—Mitoxantrone—sarcoma	0.00431	0.00678	CcSEcCtD
Mepivacaine—Sweating increased—Etoposide—sarcoma	0.00429	0.00674	CcSEcCtD
Mepivacaine—Erythema—Thiotepa—sarcoma	0.00427	0.00671	CcSEcCtD
Mepivacaine—Erythema—Dactinomycin—sarcoma	0.00424	0.00666	CcSEcCtD
Mepivacaine—Tension—Thiotepa—sarcoma	0.00419	0.00659	CcSEcCtD
Mepivacaine—SCN8A—Developmental Biology—MYOG—sarcoma	0.00417	0.0118	CbGpPWpGaD
Mepivacaine—Nervousness—Thiotepa—sarcoma	0.00415	0.00652	CcSEcCtD
Mepivacaine—Back pain—Thiotepa—sarcoma	0.00413	0.00649	CcSEcCtD
Mepivacaine—Atrioventricular block—Epirubicin—sarcoma	0.00405	0.00638	CcSEcCtD
Mepivacaine—Vision blurred—Thiotepa—sarcoma	0.00402	0.00633	CcSEcCtD
Mepivacaine—Agitation—Thiotepa—sarcoma	0.00392	0.00617	CcSEcCtD
Mepivacaine—SCN5A—Cardiac Progenitor Differentiation—PDGFRA—sarcoma	0.00382	0.0108	CbGpPWpGaD
Mepivacaine—Chills—Mitoxantrone—sarcoma	0.0038	0.00598	CcSEcCtD
Mepivacaine—Atrioventricular block—Doxorubicin—sarcoma	0.00375	0.0059	CcSEcCtD
Mepivacaine—Convulsion—Thiotepa—sarcoma	0.0037	0.00582	CcSEcCtD
Mepivacaine—Erythema—Mitoxantrone—sarcoma	0.00369	0.0058	CcSEcCtD
Mepivacaine—Hypertension—Thiotepa—sarcoma	0.00369	0.0058	CcSEcCtD
Mepivacaine—Back pain—Vincristine—sarcoma	0.00366	0.00576	CcSEcCtD
Mepivacaine—Anxiety—Thiotepa—sarcoma	0.00362	0.0057	CcSEcCtD
Mepivacaine—SCN9A—Axon guidance—EZR—sarcoma	0.00358	0.0101	CbGpPWpGaD
Mepivacaine—Back pain—Mitoxantrone—sarcoma	0.00357	0.00561	CcSEcCtD
Mepivacaine—Agitation—Vincristine—sarcoma	0.00348	0.00547	CcSEcCtD
Mepivacaine—Vision blurred—Mitoxantrone—sarcoma	0.00347	0.00546	CcSEcCtD
Mepivacaine—Oedema—Dactinomycin—sarcoma	0.00346	0.00544	CcSEcCtD
Mepivacaine—SCN3A—Axon guidance—EZR—sarcoma	0.00342	0.00968	CbGpPWpGaD
Mepivacaine—Tachycardia—Thiotepa—sarcoma	0.0034	0.00535	CcSEcCtD
Mepivacaine—SCN9A—Developmental Biology—MYOG—sarcoma	0.00337	0.00953	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—EZR—sarcoma	0.00329	0.0093	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—EZR—sarcoma	0.00329	0.0093	CbGpPWpGaD
Mepivacaine—Convulsion—Vincristine—sarcoma	0.00328	0.00516	CcSEcCtD
Mepivacaine—Hypertension—Vincristine—sarcoma	0.00327	0.00514	CcSEcCtD
Mepivacaine—SCN3A—Developmental Biology—MYOG—sarcoma	0.00322	0.00912	CbGpPWpGaD
Mepivacaine—SCN5A—Cardiac Progenitor Differentiation—KDR—sarcoma	0.00321	0.00909	CbGpPWpGaD
Mepivacaine—Convulsion—Mitoxantrone—sarcoma	0.00319	0.00502	CcSEcCtD
Mepivacaine—Hypertension—Mitoxantrone—sarcoma	0.00318	0.00501	CcSEcCtD
Mepivacaine—SCN10A—Axon guidance—EZR—sarcoma	0.00317	0.00897	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—EZR—sarcoma	0.00317	0.00897	CbGpPWpGaD
Mepivacaine—Chills—Etoposide—sarcoma	0.00316	0.00497	CcSEcCtD
Mepivacaine—SCN8A—Developmental Biology—EZR—sarcoma	0.00316	0.00893	CbGpPWpGaD
Mepivacaine—Paraesthesia—Thiotepa—sarcoma	0.00313	0.00492	CcSEcCtD
Mepivacaine—Anxiety—Mitoxantrone—sarcoma	0.00313	0.00492	CcSEcCtD
Mepivacaine—SCN4A—Developmental Biology—MYOG—sarcoma	0.0031	0.00876	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—MYOG—sarcoma	0.0031	0.00876	CbGpPWpGaD
Mepivacaine—Somnolence—Thiotepa—sarcoma	0.0031	0.00487	CcSEcCtD
Mepivacaine—Anaphylactic shock—Vincristine—sarcoma	0.00309	0.00486	CcSEcCtD
Mepivacaine—Oedema—Vincristine—sarcoma	0.00309	0.00486	CcSEcCtD
Mepivacaine—Oedema—Mitoxantrone—sarcoma	0.00301	0.00473	CcSEcCtD
Mepivacaine—Anaphylactic shock—Mitoxantrone—sarcoma	0.00301	0.00473	CcSEcCtD
Mepivacaine—SCN10A—Developmental Biology—MYOG—sarcoma	0.00299	0.00845	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—MYOG—sarcoma	0.00299	0.00845	CbGpPWpGaD
Mepivacaine—Hyperhidrosis—Vincristine—sarcoma	0.00299	0.0047	CcSEcCtD
Mepivacaine—Back pain—Etoposide—sarcoma	0.00297	0.00467	CcSEcCtD
Mepivacaine—Shock—Mitoxantrone—sarcoma	0.00296	0.00466	CcSEcCtD
Mepivacaine—SCN5A—Cardiac Progenitor Differentiation—KIT—sarcoma	0.00296	0.00837	CbGpPWpGaD
Mepivacaine—Anaphylactoid reaction—Epirubicin—sarcoma	0.00295	0.00464	CcSEcCtD
Mepivacaine—Tachycardia—Mitoxantrone—sarcoma	0.00294	0.00462	CcSEcCtD
Mepivacaine—Hyperhidrosis—Mitoxantrone—sarcoma	0.00291	0.00457	CcSEcCtD
Mepivacaine—Hypotension—Vincristine—sarcoma	0.00289	0.00454	CcSEcCtD
Mepivacaine—Hypotension—Mitoxantrone—sarcoma	0.00281	0.00442	CcSEcCtD
Mepivacaine—Paraesthesia—Vincristine—sarcoma	0.00277	0.00436	CcSEcCtD
Mepivacaine—Urticaria—Thiotepa—sarcoma	0.00277	0.00435	CcSEcCtD
Mepivacaine—Body temperature increased—Thiotepa—sarcoma	0.00275	0.00433	CcSEcCtD
Mepivacaine—Body temperature increased—Dactinomycin—sarcoma	0.00273	0.0043	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Doxorubicin—sarcoma	0.00273	0.00429	CcSEcCtD
Mepivacaine—Cardiac arrest—Epirubicin—sarcoma	0.00271	0.00427	CcSEcCtD
Mepivacaine—Paraesthesia—Mitoxantrone—sarcoma	0.0027	0.00425	CcSEcCtD
Mepivacaine—Loss of consciousness—Etoposide—sarcoma	0.0027	0.00424	CcSEcCtD
Mepivacaine—Somnolence—Mitoxantrone—sarcoma	0.00268	0.00421	CcSEcCtD
Mepivacaine—Convulsion—Etoposide—sarcoma	0.00266	0.00418	CcSEcCtD
Mepivacaine—Hypertension—Etoposide—sarcoma	0.00265	0.00416	CcSEcCtD
Mepivacaine—SCN8A—Axon guidance—PTPRC—sarcoma	0.00261	0.00738	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—MYOD1—sarcoma	0.00258	0.00728	CbGpPWpGaD
Mepivacaine—Hypersensitivity—Thiotepa—sarcoma	0.00257	0.00404	CcSEcCtD
Mepivacaine—SCN9A—Developmental Biology—EZR—sarcoma	0.00255	0.00722	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—PLCG1—sarcoma	0.00255	0.00722	CbGpPWpGaD
Mepivacaine—Hypersensitivity—Dactinomycin—sarcoma	0.00255	0.00401	CcSEcCtD
Mepivacaine—Cardiac arrest—Doxorubicin—sarcoma	0.00251	0.00395	CcSEcCtD
Mepivacaine—Anaphylactic shock—Etoposide—sarcoma	0.0025	0.00394	CcSEcCtD
Mepivacaine—Asthenia—Thiotepa—sarcoma	0.0025	0.00393	CcSEcCtD
Mepivacaine—Asthenia—Dactinomycin—sarcoma	0.00248	0.0039	CcSEcCtD
Mepivacaine—Pruritus—Thiotepa—sarcoma	0.00247	0.00388	CcSEcCtD
Mepivacaine—SCN3A—Developmental Biology—EZR—sarcoma	0.00244	0.00691	CbGpPWpGaD
Mepivacaine—Tachycardia—Etoposide—sarcoma	0.00244	0.00384	CcSEcCtD
Mepivacaine—Body temperature increased—Vincristine—sarcoma	0.00244	0.00384	CcSEcCtD
Mepivacaine—Hyperhidrosis—Etoposide—sarcoma	0.00242	0.00381	CcSEcCtD
Mepivacaine—Urticaria—Mitoxantrone—sarcoma	0.00239	0.00376	CcSEcCtD
Mepivacaine—Body temperature increased—Mitoxantrone—sarcoma	0.00238	0.00374	CcSEcCtD
Mepivacaine—SCN2A—Developmental Biology—EZR—sarcoma	0.00235	0.00664	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—EZR—sarcoma	0.00235	0.00664	CbGpPWpGaD
Mepivacaine—Hypotension—Etoposide—sarcoma	0.00234	0.00368	CcSEcCtD
Mepivacaine—Dizziness—Thiotepa—sarcoma	0.0023	0.00362	CcSEcCtD
Mepivacaine—Hypersensitivity—Vincristine—sarcoma	0.00228	0.00358	CcSEcCtD
Mepivacaine—SCN1A—Developmental Biology—EZR—sarcoma	0.00226	0.0064	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—EZR—sarcoma	0.00226	0.0064	CbGpPWpGaD
Mepivacaine—Paraesthesia—Etoposide—sarcoma	0.00225	0.00353	CcSEcCtD
Mepivacaine—SCN8A—L1CAM interactions—SRC—sarcoma	0.00224	0.00634	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—EZR—sarcoma	0.00223	0.00631	CbGpPWpGaD
Mepivacaine—Somnolence—Etoposide—sarcoma	0.00223	0.0035	CcSEcCtD
Mepivacaine—Hypersensitivity—Mitoxantrone—sarcoma	0.00222	0.00349	CcSEcCtD
Mepivacaine—Asthenia—Vincristine—sarcoma	0.00222	0.00349	CcSEcCtD
Mepivacaine—Vomiting—Thiotepa—sarcoma	0.00222	0.00348	CcSEcCtD
Mepivacaine—Drowsiness—Epirubicin—sarcoma	0.0022	0.00346	CcSEcCtD
Mepivacaine—Vomiting—Dactinomycin—sarcoma	0.0022	0.00346	CcSEcCtD
Mepivacaine—Headache—Thiotepa—sarcoma	0.00218	0.00343	CcSEcCtD
Mepivacaine—Asthenia—Mitoxantrone—sarcoma	0.00216	0.0034	CcSEcCtD
Mepivacaine—SCN9A—Axon guidance—PTPRC—sarcoma	0.00211	0.00597	CbGpPWpGaD
Mepivacaine—Sweating—Epirubicin—sarcoma	0.00211	0.00332	CcSEcCtD
Mepivacaine—SCN5A—Developmental Biology—MYOG—sarcoma	0.0021	0.00594	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—MYOD1—sarcoma	0.00208	0.00589	CbGpPWpGaD
Mepivacaine—Nausea—Thiotepa—sarcoma	0.00207	0.00325	CcSEcCtD
Mepivacaine—SCN9A—Axon guidance—PLCG1—sarcoma	0.00206	0.00584	CbGpPWpGaD
Mepivacaine—Nausea—Dactinomycin—sarcoma	0.00205	0.00323	CcSEcCtD
Mepivacaine—Dizziness—Vincristine—sarcoma	0.00204	0.00321	CcSEcCtD
Mepivacaine—Drowsiness—Doxorubicin—sarcoma	0.00204	0.0032	CcSEcCtD
Mepivacaine—SCN3A—Axon guidance—PTPRC—sarcoma	0.00202	0.00571	CbGpPWpGaD
Mepivacaine—Bradycardia—Epirubicin—sarcoma	0.00201	0.00316	CcSEcCtD
Mepivacaine—SCN3A—Developmental Biology—MYOD1—sarcoma	0.00199	0.00563	CbGpPWpGaD
Mepivacaine—Urticaria—Etoposide—sarcoma	0.00199	0.00313	CcSEcCtD
Mepivacaine—Body temperature increased—Etoposide—sarcoma	0.00198	0.00311	CcSEcCtD
Mepivacaine—SCN3A—Axon guidance—PLCG1—sarcoma	0.00198	0.00559	CbGpPWpGaD
Mepivacaine—SCN8A—L1CAM interactions—EGFR—sarcoma	0.00197	0.00556	CbGpPWpGaD
Mepivacaine—Vomiting—Vincristine—sarcoma	0.00196	0.00309	CcSEcCtD
Mepivacaine—Sweating—Doxorubicin—sarcoma	0.00195	0.00307	CcSEcCtD
Mepivacaine—SCN4A—Axon guidance—PTPRC—sarcoma	0.00194	0.00548	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—PTPRC—sarcoma	0.00194	0.00548	CbGpPWpGaD
Mepivacaine—Headache—Vincristine—sarcoma	0.00194	0.00304	CcSEcCtD
Mepivacaine—SCN4A—Developmental Biology—MYOD1—sarcoma	0.00191	0.00541	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—MYOD1—sarcoma	0.00191	0.00541	CbGpPWpGaD
Mepivacaine—Vomiting—Mitoxantrone—sarcoma	0.00191	0.00301	CcSEcCtD
Mepivacaine—SCN4A—Axon guidance—PLCG1—sarcoma	0.0019	0.00537	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—PLCG1—sarcoma	0.0019	0.00537	CbGpPWpGaD
Mepivacaine—Headache—Mitoxantrone—sarcoma	0.00189	0.00296	CcSEcCtD
Mepivacaine—SCN1A—Axon guidance—PTPRC—sarcoma	0.00187	0.00529	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—PTPRC—sarcoma	0.00187	0.00529	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—PTPRC—sarcoma	0.00186	0.00526	CbGpPWpGaD
Mepivacaine—Bradycardia—Doxorubicin—sarcoma	0.00186	0.00293	CcSEcCtD
Mepivacaine—SCN10A—Developmental Biology—MYOD1—sarcoma	0.00185	0.00522	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—MYOD1—sarcoma	0.00185	0.00522	CbGpPWpGaD
Mepivacaine—Hypersensitivity—Etoposide—sarcoma	0.00184	0.0029	CcSEcCtD
Mepivacaine—Tinnitus—Epirubicin—sarcoma	0.00184	0.0029	CcSEcCtD
Mepivacaine—Nausea—Vincristine—sarcoma	0.00184	0.00289	CcSEcCtD
Mepivacaine—SCN10A—Axon guidance—PLCG1—sarcoma	0.00183	0.00517	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—PLCG1—sarcoma	0.00183	0.00517	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—PLCG1—sarcoma	0.00182	0.00515	CbGpPWpGaD
Mepivacaine—SCN9A—L1CAM interactions—SRC—sarcoma	0.00181	0.00513	CbGpPWpGaD
Mepivacaine—Asthenia—Etoposide—sarcoma	0.0018	0.00282	CcSEcCtD
Mepivacaine—Nausea—Mitoxantrone—sarcoma	0.00179	0.00281	CcSEcCtD
Mepivacaine—Chills—Epirubicin—sarcoma	0.00177	0.00279	CcSEcCtD
Mepivacaine—Pruritus—Etoposide—sarcoma	0.00177	0.00278	CcSEcCtD
Mepivacaine—SCN3A—L1CAM interactions—SRC—sarcoma	0.00174	0.00491	CbGpPWpGaD
Mepivacaine—Erythema—Epirubicin—sarcoma	0.00172	0.0027	CcSEcCtD
Mepivacaine—Tinnitus—Doxorubicin—sarcoma	0.0017	0.00268	CcSEcCtD
Mepivacaine—Tension—Epirubicin—sarcoma	0.00169	0.00265	CcSEcCtD
Mepivacaine—Nervousness—Epirubicin—sarcoma	0.00167	0.00263	CcSEcCtD
Mepivacaine—SCN4A—L1CAM interactions—SRC—sarcoma	0.00167	0.00471	CbGpPWpGaD
Mepivacaine—SCN2A—L1CAM interactions—SRC—sarcoma	0.00167	0.00471	CbGpPWpGaD
Mepivacaine—Back pain—Epirubicin—sarcoma	0.00166	0.00262	CcSEcCtD
Mepivacaine—Dizziness—Etoposide—sarcoma	0.00166	0.0026	CcSEcCtD
Mepivacaine—Chills—Doxorubicin—sarcoma	0.00164	0.00258	CcSEcCtD
Mepivacaine—Vision blurred—Epirubicin—sarcoma	0.00162	0.00255	CcSEcCtD
Mepivacaine—SCN1A—L1CAM interactions—SRC—sarcoma	0.00161	0.00455	CbGpPWpGaD
Mepivacaine—SCN10A—L1CAM interactions—SRC—sarcoma	0.00161	0.00455	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—EZR—sarcoma	0.00159	0.0045	CbGpPWpGaD
Mepivacaine—Vomiting—Etoposide—sarcoma	0.00159	0.0025	CcSEcCtD
Mepivacaine—Erythema—Doxorubicin—sarcoma	0.00159	0.0025	CcSEcCtD
Mepivacaine—SCN9A—L1CAM interactions—EGFR—sarcoma	0.00159	0.0045	CbGpPWpGaD
Mepivacaine—Agitation—Epirubicin—sarcoma	0.00158	0.00248	CcSEcCtD
Mepivacaine—Headache—Etoposide—sarcoma	0.00157	0.00247	CcSEcCtD
Mepivacaine—Tension—Doxorubicin—sarcoma	0.00156	0.00245	CcSEcCtD
Mepivacaine—Nervousness—Doxorubicin—sarcoma	0.00154	0.00243	CcSEcCtD
Mepivacaine—Syncope—Epirubicin—sarcoma	0.00154	0.00242	CcSEcCtD
Mepivacaine—Back pain—Doxorubicin—sarcoma	0.00154	0.00242	CcSEcCtD
Mepivacaine—SCN3A—L1CAM interactions—EGFR—sarcoma	0.00152	0.0043	CbGpPWpGaD
Mepivacaine—Loss of consciousness—Epirubicin—sarcoma	0.00151	0.00238	CcSEcCtD
Mepivacaine—SCN9A—Developmental Biology—PTPRC—sarcoma	0.00151	0.00426	CbGpPWpGaD
Mepivacaine—Vision blurred—Doxorubicin—sarcoma	0.0015	0.00236	CcSEcCtD
Mepivacaine—SCN8A—Axon guidance—KDR—sarcoma	0.0015	0.00424	CbGpPWpGaD
Mepivacaine—Convulsion—Epirubicin—sarcoma	0.00149	0.00234	CcSEcCtD
Mepivacaine—Nausea—Etoposide—sarcoma	0.00149	0.00234	CcSEcCtD
Mepivacaine—Hypertension—Epirubicin—sarcoma	0.00148	0.00233	CcSEcCtD
Mepivacaine—SCN9A—Developmental Biology—PLCG1—sarcoma	0.00147	0.00417	CbGpPWpGaD
Mepivacaine—Agitation—Doxorubicin—sarcoma	0.00146	0.0023	CcSEcCtD
Mepivacaine—SCN4A—L1CAM interactions—EGFR—sarcoma	0.00146	0.00413	CbGpPWpGaD
Mepivacaine—SCN2A—L1CAM interactions—EGFR—sarcoma	0.00146	0.00413	CbGpPWpGaD
Mepivacaine—Anxiety—Epirubicin—sarcoma	0.00146	0.00229	CcSEcCtD
Mepivacaine—SCN3A—Developmental Biology—PTPRC—sarcoma	0.00144	0.00407	CbGpPWpGaD
Mepivacaine—Syncope—Doxorubicin—sarcoma	0.00143	0.00224	CcSEcCtD
Mepivacaine—SCN3A—Developmental Biology—PLCG1—sarcoma	0.00141	0.00399	CbGpPWpGaD
Mepivacaine—SCN10A—L1CAM interactions—EGFR—sarcoma	0.00141	0.00398	CbGpPWpGaD
Mepivacaine—SCN1A—L1CAM interactions—EGFR—sarcoma	0.00141	0.00398	CbGpPWpGaD
Mepivacaine—Anaphylactic shock—Epirubicin—sarcoma	0.0014	0.00221	CcSEcCtD
Mepivacaine—Oedema—Epirubicin—sarcoma	0.0014	0.00221	CcSEcCtD
Mepivacaine—Loss of consciousness—Doxorubicin—sarcoma	0.0014	0.0022	CcSEcCtD
Mepivacaine—SCN2A—Developmental Biology—PTPRC—sarcoma	0.00138	0.00391	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—PTPRC—sarcoma	0.00138	0.00391	CbGpPWpGaD
Mepivacaine—Shock—Epirubicin—sarcoma	0.00138	0.00217	CcSEcCtD
Mepivacaine—Convulsion—Doxorubicin—sarcoma	0.00138	0.00217	CcSEcCtD
Mepivacaine—Hypertension—Doxorubicin—sarcoma	0.00137	0.00216	CcSEcCtD
Mepivacaine—Tachycardia—Epirubicin—sarcoma	0.00137	0.00215	CcSEcCtD
Mepivacaine—Hyperhidrosis—Epirubicin—sarcoma	0.00136	0.00213	CcSEcCtD
Mepivacaine—SCN4A—Developmental Biology—PLCG1—sarcoma	0.00135	0.00383	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—PLCG1—sarcoma	0.00135	0.00383	CbGpPWpGaD
Mepivacaine—Anxiety—Doxorubicin—sarcoma	0.00135	0.00212	CcSEcCtD
Mepivacaine—SCN1A—Developmental Biology—PTPRC—sarcoma	0.00133	0.00377	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—PTPRC—sarcoma	0.00133	0.00377	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—PTPRC—sarcoma	0.00131	0.00372	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—CREB1—sarcoma	0.00131	0.00372	CbGpPWpGaD
Mepivacaine—Hypotension—Epirubicin—sarcoma	0.00131	0.00206	CcSEcCtD
Mepivacaine—SCN10A—Developmental Biology—PLCG1—sarcoma	0.00131	0.00369	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—PLCG1—sarcoma	0.00131	0.00369	CbGpPWpGaD
Mepivacaine—Anaphylactic shock—Doxorubicin—sarcoma	0.0013	0.00204	CcSEcCtD
Mepivacaine—Oedema—Doxorubicin—sarcoma	0.0013	0.00204	CcSEcCtD
Mepivacaine—SCN5A—Developmental Biology—MYOD1—sarcoma	0.0013	0.00367	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—FOXO1—sarcoma	0.00129	0.00366	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—PLCG1—sarcoma	0.00129	0.00364	CbGpPWpGaD
Mepivacaine—Shock—Doxorubicin—sarcoma	0.00128	0.00201	CcSEcCtD
Mepivacaine—Tachycardia—Doxorubicin—sarcoma	0.00127	0.00199	CcSEcCtD
Mepivacaine—Paraesthesia—Epirubicin—sarcoma	0.00126	0.00198	CcSEcCtD
Mepivacaine—Hyperhidrosis—Doxorubicin—sarcoma	0.00126	0.00197	CcSEcCtD
Mepivacaine—Somnolence—Epirubicin—sarcoma	0.00125	0.00196	CcSEcCtD
Mepivacaine—SCN8A—Axon guidance—MMP2—sarcoma	0.00122	0.00346	CbGpPWpGaD
Mepivacaine—Hypotension—Doxorubicin—sarcoma	0.00121	0.00191	CcSEcCtD
Mepivacaine—SCN9A—Axon guidance—KDR—sarcoma	0.00121	0.00343	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—CREB1—sarcoma	0.00119	0.00336	CbGpPWpGaD
Mepivacaine—Paraesthesia—Doxorubicin—sarcoma	0.00117	0.00183	CcSEcCtD
Mepivacaine—SCN3A—Axon guidance—KDR—sarcoma	0.00116	0.00328	CbGpPWpGaD
Mepivacaine—Somnolence—Doxorubicin—sarcoma	0.00115	0.00181	CcSEcCtD
Mepivacaine—SCN5A—L1CAM interactions—SRC—sarcoma	0.00113	0.0032	CbGpPWpGaD
Mepivacaine—Urticaria—Epirubicin—sarcoma	0.00111	0.00175	CcSEcCtD
Mepivacaine—SCN4A—Axon guidance—KDR—sarcoma	0.00111	0.00315	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—KDR—sarcoma	0.00111	0.00315	CbGpPWpGaD
Mepivacaine—Body temperature increased—Epirubicin—sarcoma	0.00111	0.00174	CcSEcCtD
Mepivacaine—SCN1A—Axon guidance—KDR—sarcoma	0.00107	0.00304	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—KDR—sarcoma	0.00107	0.00304	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—KDR—sarcoma	0.00107	0.00302	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—CREB1—sarcoma	0.00106	0.00301	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—FOXO1—sarcoma	0.00105	0.00296	CbGpPWpGaD
Mepivacaine—Hypersensitivity—Epirubicin—sarcoma	0.00103	0.00163	CcSEcCtD
Mepivacaine—Urticaria—Doxorubicin—sarcoma	0.00103	0.00162	CcSEcCtD
Mepivacaine—Body temperature increased—Doxorubicin—sarcoma	0.00103	0.00161	CcSEcCtD
Mepivacaine—SCN3A—Axon guidance—CREB1—sarcoma	0.00102	0.00287	CbGpPWpGaD
Mepivacaine—Asthenia—Epirubicin—sarcoma	0.00101	0.00158	CcSEcCtD
Mepivacaine—SCN3A—Developmental Biology—FOXO1—sarcoma	0.001	0.00283	CbGpPWpGaD
Mepivacaine—Pruritus—Epirubicin—sarcoma	0.000993	0.00156	CcSEcCtD
Mepivacaine—SCN5A—L1CAM interactions—EGFR—sarcoma	0.000991	0.0028	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—MMP2—sarcoma	0.000989	0.0028	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—CREB1—sarcoma	0.000977	0.00276	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—CREB1—sarcoma	0.000977	0.00276	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—FOXO1—sarcoma	0.000961	0.00272	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—FOXO1—sarcoma	0.000961	0.00272	CbGpPWpGaD
Mepivacaine—Hypersensitivity—Doxorubicin—sarcoma	0.000956	0.0015	CcSEcCtD
Mepivacaine—SCN3A—Axon guidance—MMP2—sarcoma	0.000946	0.00268	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—CREB1—sarcoma	0.000942	0.00266	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—CREB1—sarcoma	0.000942	0.00266	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—PTPRC—sarcoma	0.000938	0.00265	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—CREB1—sarcoma	0.000938	0.00265	CbGpPWpGaD
Mepivacaine—Asthenia—Doxorubicin—sarcoma	0.000931	0.00146	CcSEcCtD
Mepivacaine—Dizziness—Epirubicin—sarcoma	0.000928	0.00146	CcSEcCtD
Mepivacaine—SCN1A—Developmental Biology—FOXO1—sarcoma	0.000926	0.00262	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—FOXO1—sarcoma	0.000926	0.00262	CbGpPWpGaD
Mepivacaine—Pruritus—Doxorubicin—sarcoma	0.000918	0.00144	CcSEcCtD
Mepivacaine—SCN5A—Developmental Biology—PLCG1—sarcoma	0.000918	0.0026	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—MMP2—sarcoma	0.000909	0.00257	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—MMP2—sarcoma	0.000909	0.00257	CbGpPWpGaD
Mepivacaine—Vomiting—Epirubicin—sarcoma	0.000892	0.0014	CcSEcCtD
Mepivacaine—Headache—Epirubicin—sarcoma	0.000879	0.00138	CcSEcCtD
Mepivacaine—SCN10A—Axon guidance—MMP2—sarcoma	0.000877	0.00248	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—MMP2—sarcoma	0.000877	0.00248	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—MMP2—sarcoma	0.000873	0.00247	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—KDR—sarcoma	0.000865	0.00245	CbGpPWpGaD
Mepivacaine—Dizziness—Doxorubicin—sarcoma	0.000858	0.00135	CcSEcCtD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—JUN—sarcoma	0.000854	0.00242	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—CTNNB1—sarcoma	0.000848	0.0024	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—SRC—sarcoma	0.000848	0.0024	CbGpPWpGaD
Mepivacaine—Nausea—Epirubicin—sarcoma	0.000833	0.00131	CcSEcCtD
Mepivacaine—SCN3A—Developmental Biology—KDR—sarcoma	0.000827	0.00234	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—VEGFA—sarcoma	0.000826	0.00233	CbGpPWpGaD
Mepivacaine—Vomiting—Doxorubicin—sarcoma	0.000825	0.0013	CcSEcCtD
Mepivacaine—SCN8A—Axon guidance—NRAS—sarcoma	0.000815	0.00231	CbGpPWpGaD
Mepivacaine—Headache—Doxorubicin—sarcoma	0.000813	0.00128	CcSEcCtD
Mepivacaine—SCN2A—Developmental Biology—KDR—sarcoma	0.000795	0.00225	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—KDR—sarcoma	0.000795	0.00225	CbGpPWpGaD
Mepivacaine—Nausea—Doxorubicin—sarcoma	0.000771	0.00121	CcSEcCtD
Mepivacaine—SCN1A—Developmental Biology—KDR—sarcoma	0.000766	0.00217	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—KDR—sarcoma	0.000766	0.00217	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—CREB1—sarcoma	0.000758	0.00214	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—KDR—sarcoma	0.000755	0.00213	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—VEGFA—sarcoma	0.000746	0.00211	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—EGFR—sarcoma	0.000743	0.0021	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—CREB1—sarcoma	0.000725	0.00205	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—MMP2—sarcoma	0.000706	0.002	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—KRAS—sarcoma	0.000702	0.00198	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—CREB1—sarcoma	0.000697	0.00197	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—CREB1—sarcoma	0.000697	0.00197	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—SRC—sarcoma	0.000686	0.00194	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—MMP2—sarcoma	0.000675	0.00191	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—CREB1—sarcoma	0.000672	0.0019	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—CREB1—sarcoma	0.000672	0.0019	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—CTNNB1—sarcoma	0.000669	0.00189	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—VEGFA—sarcoma	0.000668	0.00189	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—CREB1—sarcoma	0.000662	0.00187	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—NRAS—sarcoma	0.00066	0.00186	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—SRC—sarcoma	0.000656	0.00185	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—FOXO1—sarcoma	0.000651	0.00184	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—MMP2—sarcoma	0.000649	0.00183	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—MMP2—sarcoma	0.000649	0.00183	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—VEGFA—sarcoma	0.000639	0.00181	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—NRAS—sarcoma	0.000631	0.00178	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—SRC—sarcoma	0.00063	0.00178	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—SRC—sarcoma	0.00063	0.00178	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—MMP2—sarcoma	0.000626	0.00177	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—MMP2—sarcoma	0.000626	0.00177	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—MMP2—sarcoma	0.000616	0.00174	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—VEGFA—sarcoma	0.000614	0.00174	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—VEGFA—sarcoma	0.000614	0.00174	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—SRC—sarcoma	0.000607	0.00172	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—SRC—sarcoma	0.000607	0.00172	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—NRAS—sarcoma	0.000606	0.00171	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—NRAS—sarcoma	0.000606	0.00171	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—SRC—sarcoma	0.000605	0.00171	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—EGFR—sarcoma	0.000601	0.0017	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—HRAS—sarcoma	0.000597	0.00169	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—VEGFA—sarcoma	0.000592	0.00167	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—VEGFA—sarcoma	0.000592	0.00167	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—VEGFA—sarcoma	0.000589	0.00167	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—NRAS—sarcoma	0.000584	0.00165	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—NRAS—sarcoma	0.000584	0.00165	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—NRAS—sarcoma	0.000582	0.00165	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—EGFR—sarcoma	0.000575	0.00163	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—KRAS—sarcoma	0.000568	0.00161	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—EGFR—sarcoma	0.000552	0.00156	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—EGFR—sarcoma	0.000552	0.00156	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—KRAS—sarcoma	0.000543	0.00154	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—CTNNB1—sarcoma	0.000541	0.00153	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—KDR—sarcoma	0.000539	0.00152	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—EGFR—sarcoma	0.000532	0.00151	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—EGFR—sarcoma	0.000532	0.00151	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—EGFR—sarcoma	0.00053	0.0015	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—KRAS—sarcoma	0.000522	0.00148	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—KRAS—sarcoma	0.000522	0.00148	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—CTNNB1—sarcoma	0.000518	0.00146	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—KRAS—sarcoma	0.000503	0.00142	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—KRAS—sarcoma	0.000503	0.00142	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—KRAS—sarcoma	0.000501	0.00142	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—CTNNB1—sarcoma	0.000497	0.00141	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—CTNNB1—sarcoma	0.000497	0.00141	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—SRC—sarcoma	0.000489	0.00138	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—HRAS—sarcoma	0.000482	0.00136	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—CTNNB1—sarcoma	0.00048	0.00136	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—CTNNB1—sarcoma	0.00048	0.00136	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—VEGFA—sarcoma	0.000476	0.00135	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—CREB1—sarcoma	0.000472	0.00134	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—NRAS—sarcoma	0.000471	0.00133	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—SRC—sarcoma	0.000468	0.00132	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—HRAS—sarcoma	0.000461	0.0013	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—VEGFA—sarcoma	0.000456	0.00129	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—NRAS—sarcoma	0.00045	0.00127	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—SRC—sarcoma	0.00045	0.00127	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—SRC—sarcoma	0.00045	0.00127	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—HRAS—sarcoma	0.000443	0.00125	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—HRAS—sarcoma	0.000443	0.00125	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—MMP2—sarcoma	0.00044	0.00124	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—VEGFA—sarcoma	0.000438	0.00124	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—VEGFA—sarcoma	0.000438	0.00124	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—SRC—sarcoma	0.000433	0.00123	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—SRC—sarcoma	0.000433	0.00123	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—NRAS—sarcoma	0.000432	0.00122	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—NRAS—sarcoma	0.000432	0.00122	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—EGFR—sarcoma	0.000429	0.00121	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—HRAS—sarcoma	0.000428	0.00121	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—HRAS—sarcoma	0.000428	0.00121	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—SRC—sarcoma	0.000427	0.00121	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—HRAS—sarcoma	0.000426	0.0012	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—VEGFA—sarcoma	0.000422	0.00119	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—VEGFA—sarcoma	0.000422	0.00119	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—NRAS—sarcoma	0.000417	0.00118	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—NRAS—sarcoma	0.000417	0.00118	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—VEGFA—sarcoma	0.000416	0.00118	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—NRAS—sarcoma	0.000411	0.00116	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—EGFR—sarcoma	0.00041	0.00116	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—KRAS—sarcoma	0.000405	0.00115	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—EGFR—sarcoma	0.000394	0.00111	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—EGFR—sarcoma	0.000394	0.00111	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—KRAS—sarcoma	0.000387	0.0011	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—EGFR—sarcoma	0.00038	0.00107	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—EGFR—sarcoma	0.00038	0.00107	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—EGFR—sarcoma	0.000374	0.00106	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—KRAS—sarcoma	0.000372	0.00105	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—KRAS—sarcoma	0.000372	0.00105	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—KRAS—sarcoma	0.000359	0.00101	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—KRAS—sarcoma	0.000359	0.00101	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—KRAS—sarcoma	0.000354	0.001	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—HRAS—sarcoma	0.000344	0.000974	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—CTNNB1—sarcoma	0.000337	0.000953	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—HRAS—sarcoma	0.000329	0.000931	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—HRAS—sarcoma	0.000316	0.000895	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—HRAS—sarcoma	0.000316	0.000895	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—HRAS—sarcoma	0.000305	0.000863	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—HRAS—sarcoma	0.000305	0.000863	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—SRC—sarcoma	0.000305	0.000862	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—HRAS—sarcoma	0.000301	0.00085	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—VEGFA—sarcoma	0.000297	0.000839	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—NRAS—sarcoma	0.000293	0.000829	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—EGFR—sarcoma	0.000267	0.000755	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—KRAS—sarcoma	0.000252	0.000714	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—HRAS—sarcoma	0.000214	0.000607	CbGpPWpGaD
